Cargando…
H-RACS: a handy tool to rank anti-cancer synergistic drugs
Though promising, identifying synergistic combinations from a large pool of candidate drugs remains challenging for cancer treatment. Due to unclear mechanism and limited confirmed cases, only a few computational algorithms are able to predict drug synergy. Yet they normally require the drug-cell tr...
Autores principales: | Yan, Xinmiao, Yang, Yiyan, Chen, Zikun, Yin, Zuojing, Deng, Zeliang, Qiu, Tianyi, Tang, Kailin, Cao, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695372/ https://www.ncbi.nlm.nih.gov/pubmed/33173014 http://dx.doi.org/10.18632/aging.103925 |
Ejemplares similares
-
Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling
por: Yin, Zuojing, et al.
Publicado: (2020) -
Searching Synergistic Dose Combinations for Anticancer Drugs
por: Yin, Zuojing, et al.
Publicado: (2018) -
Reveal the Regulation Patterns of Prognosis-Related miRNAs and lncRNAs Across Solid Tumors in the Cancer Genome Atlas
por: Yin, Zuojing, et al.
Publicado: (2020) -
Rank-in: enabling integrative analysis across microarray and RNA-seq for cancer
por: Tang, Kailin, et al.
Publicado: (2021) -
Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma
por: Gao, Jian, et al.
Publicado: (2021)